Uveitis Resource Center

Editorially independent content supported with advertising.

Videos

A Basic Approach to Managing Anterior Scleritis

The Changing Face of Uveitis Treatment

More Than Just Uveitis?

Anti-TNF-alpha agents in uveitis management

Viral anterior uveitis (HSV, VZV, and CMV)

Approach to Infectious Uveitis

Vogt Koyanagi Harada

Retinal Vasculitis

A Practical Approach to Uveitic CME

Sustained Release Steroids in Uveitis

25G Vitrectomy for the Treatment of Chronic Intermediate Uveitis with Retinal Cyst

General approaches to infectious and noninfectious uveitis treatment.

Formulating a Differential

Laboratory Testing in Uveitis

Resource Center Archive

OPPORTUNITIES IN THE UVEITIS TREATMENT PIPELINE

By Quan Dong Nguyen, MD, MSc

Read more...
BASIC MANAGEMENT OF ANTERIOR SCLERITIS

By Nisha Acharya, MD

Read more...
PRACTICAL MANAGEMENT OF UVEITIC CME

By Nisha Acharya, MD

Read more...
CONSIDERATIONS IN CHRONIC UVEITIS TREATMENT

By Steven Yeh, MD

Read more...
MODERN IMAGING IMPACTS RETINAL VASCULITIS TREATMENT APPROACH

By John Huang, MD

Read more...
UVEITIS DIAGNOSTIC TESTING OPTIONS

By Steven Yeh, MD

Read more...
THE ROLE OF UVEITIS IN OTHER DISEASES

By Rajiv Shah, MD

Read more...
UVEITIS TREATMENT OPTIONS

By Sunil Srivastava, MD

Read more...
FUTURE THERAPIES FOR CHRONIC NONINFECTIOUS UVEITIS

New drugs and innovative drug delivery systems will pave the way for future treatments in uveitis.

By Emmett T. Cunningham, Jr, MD, PhD, MPH

Local and systemic corticosteroids constitute first-line therapy for virtually all patients with noninfectious uveitis.1 Prolonged corticosteroid use can produce toxic effects, however, and so corticosteroid-sparing immunomodulatory therapies (IMTs) have assumed an increasingly important role in the management of chronic ocular inflammation.2,3 Read more...
BIOLOGIC THERAPY FOR POSTERIOR UVEITIS AND PANUVEITIS

By Sirichai Pasadhika, MD; Eric B. Suhler, MD, MPH; and Emmett T. Cunningham, Jr., MD, PhD, MPH

Biologic response modifiers (often referred to as biologics) are proteins produced by recombinant DNA or monoclonal antibody technology designed to block specific mediators of the cellmediated immune response. They are mostly either recombinant antibodies or antibody-derived proteins. Monoclonal antibodies (mAb), when used as medications, are given a generic name ending in “-mab.” Read more...
REDEFINING THE PATIENT- DOCTOR RELATIONSHIP TO IMPROVE OUTCOMES IN RETINAL DISEASE

By Kishan Govind, MD; Victor T. Copeland, MD; and Shree K. Kurup, MD

Chronic conditions require dynamic treatment strategies. Read more...
RETINAL BIOPSY

By Francesco Pichi, MD; Thomas Albini, MD; and Antonio Ciardella, MD

In most cases of uveitis, a diagnosis can be made based on a patient’s medical history, clinical appearance, and basic investigations… Read more...
STUDY EXAMINES UVEITIS IN A HAWAIIAN POPULATION

By Baruch D. Kuppermann, MD, PhD

A study by Nisha R. Acharya, M.D., M.S., of the University of California, San Francisco, and colleagues examined the incidence and prevalence of uveitis (eye inflammation conditions responsible for a… Read more...

OPPORTUNITIES IN THE UVEITIS TREATMENT PIPELINE

By QUAN DONG NGUYEN, MD, MSc

Articles

Differentiating Primary Intraocular Lymphoma from Uveitis

J.W. Harbour, MD

How to diagnose and treat this rare disease. Read Article

Opportunities Arise in the Uveitis Treatment Pipeline

Quan Dong Nguyen, MD, MSc

Researchers are in pursuit of effective ways to manage this disease. Read Article

Basic Management of Anterior Scleritis

Nisha Acharya, MD, MPH

A discussion of the causes of and treatments for anterior scleritis. Read Article

Reducing Inflammation and Halting Disease Progression

Lucia Sobrin, MD, MPH

A closer look at the use of anti-TNFα agents in the treatment of various forms of uveitis. Read Article

Viral Anterior Uveitis in the Real World

Anat Galor, MD

A clinician's account of how to identify and treat this condition. Read Article

Section Chair: Thomas Albini, MD

Dr. Albini is an Associate Professor of Clinical Ophthalmology at Bascom Palmer Eye Institute in Miami and a member of the Retina Today Editorial Board.

News

Researchers Test Stem Cell–Based Retinal Implant for Dry AMD With Encouraging Results

Physicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a first-in-kind stem cell-based retinal i…

GenSight Biologics Announces Topline Results from Phase 3 Clinical Trial of GS010 in Patients with Leber Hereditary Optic Neuropathy (LHON)

GenSight Biologics announced that a phase 3 study of GS010 (rAAV2/2-ND4) in patients with Leber hereditary optic neuropathy (LHON) failed to meet its primary endpoint, with sh…

Uveitis Resource Center

Videos

A Basic Approach to Managing Anterior Scleritis

The Changing Face of Uveitis Treatment

More Than Just Uveitis?

Anti-TNF-alpha agents in uveitis management

Viral anterior uveitis (HSV, VZV, and CMV)

Approach to Infectious Uveitis

Vogt Koyanagi Harada

Retinal Vasculitis

A Practical Approach to Uveitic CME

Sustained Release Steroids in Uveitis

25G Vitrectomy for the Treatment of Chronic Intermediate Uveitis with Retinal Cyst

General approaches to infectious and noninfectious uveitis treatment.

Formulating a Differential

Laboratory Testing in Uveitis

Resource Center Archive

By Quan Dong Nguyen, MD, MSc

By Nisha Acharya, MD

By Nisha Acharya, MD

By Steven Yeh, MD

By John Huang, MD

By Steven Yeh, MD

By Rajiv Shah, MD

By Sunil Srivastava, MD

New drugs and innovative drug delivery systems will pave the way for future treatments in uveitis.

By Emmett T. Cunningham, Jr, MD, PhD, MPH

By Sirichai Pasadhika, MD; Eric B. Suhler, MD, MPH; and Emmett T. Cunningham, Jr., MD, PhD, MPH

By Kishan Govind, MD; Victor T. Copeland, MD; and Shree K. Kurup, MD

By Francesco Pichi, MD; Thomas Albini, MD; and Antonio Ciardella, MD

By Baruch D. Kuppermann, MD, PhD

By QUAN DONG NGUYEN, MD, MSc

Articles

J.W. Harbour, MD

Quan Dong Nguyen, MD, MSc

Nisha Acharya, MD, MPH

Lucia Sobrin, MD, MPH

Anat Galor, MD

Section Chair: Thomas Albini, MD

News

Centers

Contact Info

Other Resources

About Retina Today